Mayo Clinic: Atherosclerosis trials
The registry lists 10 Atherosclerosis studies with Mayo Clinic as lead sponsor. 0 are open to participants now and 2 have results posted.
Phase 1 4Phase 3 2No phase 4(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Lipoprotein-associated Phospholipase A2 (Lp-PLA2) Progenitor Cells and Coronary Atherosclerosis in HumansCompletedNCT01067339Phase 3Results posted
- The Effect of Tekturna on Endothelial Function and Endothelial Progenitor Cells in Patients With Early AtherosclerosisTerminatedNCT01067326Phase 3Results posted
- Study of Intracoronary CD34+ Cell Administration in Patients With Early Coronary AtherosclerosisCompletedNCT03471611Phase 1
- Using Ultrasonography, Shear Wave Elastography, Strain Imaging, and 3-D Volume Ultrasonography on Cardiovascular DiseaseWithdrawnNCT03335020Phase 1
- New Technologies to Determine Carotid Plaque VulnerabilityCompletedNCT02224339
- Assessment of Coronary Plaque Composition Using Optical Coherence TomographyCompletedNCT01642173Phase 1
- Assessment of Coronary Plaque CompositionCompletedNCT01581632Phase 1
- Lp-PLA2 and Coronary Atherosclerosis in HumansCompletedNCT01557088Not applicable
- Effects of EGCG-Enhanced Extra Virgin Olive Oil on Endothelial FunctionCompletedNCT00865787
- Effects of Cranberry Juice on Risk Factors for Cardiovascular DiseaseCompletedNCT00631306